Zoetis Inc. (NYSE:ZTS) marked another milestone in the company’s launch
as an independent public company today, conducting its first-ever Annual
Meeting of Shareholders. The company, which became fully independent in
June 2013 after completing its separation from Pfizer, hosted the event
this morning at the Hilton Short Hills Hotel, in Short Hills, New Jersey.
Zoetis Chairman Michael McCallister presided over the business portion
of the meeting and shareholder voting. He was joined by Zoetis Chief
Executive Officer Juan Ramón Alaix who discussed the company’s first
year as an independent company, the core strengths of its business
model, and its long-term value proposition for shareholders.
A full replay of the meeting is available at http://investor.zoetis.com/events-presentations,
along with a copy of Mr. Alaix’s prepared remarks and presentation.
Preliminary results from the Annual Meeting of Shareholders indicate the
following results of shareholder voting:
-
Gregory Norden, Louise M. Parent and Robert W. Scully have been
elected as directors for three-year terms.
-
Shareholders ratified and approved the selection of KPMG LLP as the
company’s independent registered public accounting firm for the 2014
fiscal year.
-
Shareholders voted to approve, on an advisory basis, the compensation
of the company’s named executive officers, and to approve the holding
of an advisory vote on executive compensation every year. In addition,
shareholders voted to approve the company’s 2013 Equity and Incentive
Plan.
The final results of the shareholder voting are subject to verification
by the independent election inspectors and will be filed in a Form 8-K
and available on the company’s website.
About Zoetis
Zoetis
(zô-EH-tis) is the leading animal health company, dedicated to
supporting its customers and their businesses. Building on more than 60
years of experience in animal health, Zoetis discovers, develops,
manufactures and markets veterinary vaccines and medicines, complemented
by diagnostic products and genetic tests and supported by a range of
services. In 2013, the company generated annual revenue of $4.6 billion.
With approximately 9,800 employees worldwide at the beginning of 2014,
Zoetis has a local presence in approximately 70 countries, including 28
manufacturing facilities in 11 countries. Its products serve
veterinarians, livestock producers and people who raise and care for
farm and companion animals in 120 countries. For more information, visit www.zoetis.com.
DISCLOSURE NOTICES
Forward-Looking Statements: This
press release contains forward-looking statements, which reflect the
current views of Zoetis with respect to business plans or prospects,
future operating or financial performance, expectations regarding
products, future use of cash and dividend payments, and other future
events. These statements are not guarantees of future performance or
actions. Forward-looking statements are subject to risks and
uncertainties. If one or more of these risks or uncertainties
materialize, or if management's underlying assumptions prove to be
incorrect, actual results may differ materially from those contemplated
by a forward-looking statement. Forward-looking statements speak only as
of the date on which they are made. Zoetis expressly disclaims any
obligation to update or revise any forward-looking statement, whether as
a result of new information, future events or otherwise. A
further list and description of risks, uncertainties and other matters
can be found in our Annual Report on Form 10-K for the fiscal year ended
December 31, 2013, including in the sections thereof captioned
“Forward-Looking Information and Factors That May Affect Future Results”
and “Item 1A. Risk Factors,” in our Quarterly Reports on Form 10-Q and
in our Current Reports on Form 8-K. These filings and subsequent filings
are available online at www.sec.gov,
www.zoetis.com,
or on request from Zoetis.
Internet Posting of Information:
We routinely post information that may be important to investors in
the 'Investors' section of our web site at www.zoetis.com,
on our Facebook page at http://www.facebook.com/zoetis
and on Twitter @zoetis. We encourage investors and potential investors
to consult our website regularly and to follow us on Facebook and
Twitter for important information about us.
Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20140513006585/en/
Zoetis Inc.
Media:
Bill Price, 1-973-443-2742 (o)
william.price@zoetis.com
or
Elinore White, 1-973-443-2835 (o)
elinore.y.white@zoetis.com
or
Investors:
John O'Connor, 1-973-822-7088 (o)